Quantifying Outsourcing Impact: Analysis of Preclinical CRO Market Size and Growth Metrics
The escalating cost and increasing complexity of drug development are the primary structural forces driving the expansion of the outsourced preclinical research sector, a trend clearly reflected in the rapidly expanding Preclinical CRO Market Size. Currently valued at several billion dollars, market estimates suggest a trajectory of robust compound annual growth (CAGR) well into the next...
0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр